Skip to main content
. 2020 Dec 17;3(2):100221. doi: 10.1016/j.jhepr.2020.100221

Table 2.

MIF and sCD74 serum concentrations stratified for clinical parameters and the presence and severity of ACLF.

Serum MIF (ng/ml)
Serum sCD74 (ng/ml)
Median (IQR) p value Median (IQR) p value
Sex
 Female 2.7 (1.4–6.0) 0.25 37.1 (7.2–85.0) 0.20
 Male 3.2 (1.7–7.6) 49.3 (6.1–118.7)
Aetiology
 Alcoholic 3.0 (1.5–7.3) 0.61 39.2 (6.1–111.7) 0.26
 Non-alcoholic 3.2 (1.8–6.8) 64.2 (10.2–128.4)
Child-Pugh class
 B 3.0 (1.6–7.4) 0.84 38.8 (14.7–84.8) 0.94
 C 3.1 (1.5–7.3) 48.5 (2.6–115.0)
HCC
 No 3.0 (1.5–7.2) 0.32 42.3 (5.7–111.4) 0.67
 Yes 3.5 (1.9–7.9) 50.5 (13.0–143.4)
ACLF
 No 3.0 (1.5–7.2) 0.63 46.5 (9.2–114.1) 0.67
 Yes 3.5 (1.9–7.9) 43.4 (0.6–110.9)
ACLF grade
 Grade 1 3.1 (1.7–7.1) 0.49 43.1 (1.6–147.1) 0.90
 Grade 2 3.6 (1.4–8.0) 48.9 (1.4–111.0)
 Grade 3 3.4 (2.6–8.0) 37.2 (0.4–74.3)

Medians with IQRs are depicted and p values from the Mann-Whitney U test or Kruskal-Wallis test are shown. ACLF, acute-on-chronic liver failure; HCC, hepatocellular carcinoma; MIF, macrophage migration inhibitory factor; sCD74, soluble receptor CD74.